title: Potassium lowering agents: Recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemia.
authors.affiliation: University of Michigan School of Medicine, Ann Arbor, MI, USA; Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, Inserm U1116, CHRU Nancy, Université de Lorraine, Association Lorraine de Traitement de l'Insuffisance Rénale, and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
authors.forename: Bertram
authors.initials: B
authors.lastname: Pitt
authors.affiliation: University of Michigan School of Medicine, Ann Arbor, MI, USA; Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, Inserm U1116, CHRU Nancy, Université de Lorraine, Association Lorraine de Traitement de l'Insuffisance Rénale, and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France. Electronic address: p.rossignol@chru-nancy.fr.
authors.forename: Patrick
authors.initials: P
authors.lastname: Rossignol
mesh_terms: D019468:Disease Management; D004501:Education, Medical; D006801:Humans; D006947:Hyperkalemia / Q000097:blood* / Q000188:drug therapy*; D010353:Patient Education as Topic; D010820:Physicians; D011108:Polymers / Q000627:therapeutic use*; D011137:Polystyrenes / Q000627:therapeutic use*; D011188:Potassium / Q000097:blood*
chemical_list: D011108:Polymers; D011137:Polystyrenes; C568789:patiromer; C003321:polystyrene sulfonic acid; D011188:Potassium